Plante Moran Financial Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.91K Sell
108
-214
-66% -$14.1K ﹤0.01% 597
2026
Q1
$22.9K Sell
322
-145
-31% -$11.4K ﹤0.01% 412
2025
Q4
$38.3K Buy
467
+108
+30% +$8.41K ﹤0.01% 362
2025
Q3
$27K Buy
359
+71
+25% +$5.3K ﹤0.01% 428
2025
Q2
$21.3K Sell
288
-60
-17% -$4.18K ﹤0.01% 466
2025
Q1
$28.1K Buy
348
+50
+17% +$4.3K ﹤0.01% 432
2024
Q4
$23.3K Sell
298
-25
-8% -$2.13K ﹤0.01% 468
2024
Q3
$30.3K Buy
323
+25
+8% +$2.1K ﹤0.01% 466
2024
Q2
$23.2K Hold
298
﹤0.01% 457
2024
Q1
$27.1K Sell
298
-65
-18% -$5.41K ﹤0.01% 453
2023
Q4
$28.1K Buy
363
+26
+8% +$1.82K ﹤0.01% 400
2023
Q3
$22.9K Buy
337
+72
+27% +$5.24K ﹤0.01% 407
2023
Q2
$21.5K Hold
265
﹤0.01% 431
2023
Q1
$21.7K Buy
+265
New +$18.9K ﹤0.01% 429

Other funds holding GEHC

Plante Moran Financial Advisors's GEHC Position: Q2 2026 in Review

Plante Moran Financial Advisors reduced its GE HealthCare (GEHC) stake by 66% in Q2 2026, selling an estimated $14.1K and leaving 108 shares worth $6.91K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Plante Moran Financial Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $38.3K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Plante Moran Financial Advisors held 108 shares of GE HealthCare worth $6.91K as of Q2 2026.
  • Plante Moran Financial Advisors sold 214 GE HealthCare shares in Q2 2026, an estimated $14.1K.
  • GE HealthCare made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #597 holding.
  • Plante Moran Financial Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Plante Moran Financial Advisors's GE HealthCare position peaked at $38.3K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.